Guangzhou Improve Med Instrument (300030) — Strategic Asset Allocation Index
Guangzhou Improve Med Instrument (300030) has a Strategic Asset Allocation Index of 47.0% as of June 2023. Strategic assets (PP&E of CN¥391.14 Million plus long-term investments of CN¥-) total CN¥391.14 Million, measured against net assets of CN¥832.17 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Guangzhou Improve Med Instrument Strategic Asset Allocation Index (2006–2022)
This chart shows how Guangzhou Improve Med Instrument's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of June 2023, the index stands at 47.0%, representing strategic assets of CN¥391.14 Million against net assets of CN¥832.17 Million CNY. Explore Guangzhou Improve Med Instrument (300030) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Guangzhou Improve Med Instrument (2006–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Improve Med Instrument from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Guangzhou Improve Med Instrument.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 49.6% | CN¥407.12 Million | CN¥407.12 Million | CN¥- | CN¥820.61 Million | ▲ +10.0 pp |
| 2021 | 39.6% | CN¥408.54 Million | CN¥408.54 Million | CN¥- | CN¥1.03 Billion | ▲ +5.0 pp |
| 2020 | 34.6% | CN¥347.45 Million | CN¥347.45 Million | CN¥- | CN¥1.00 Billion | ▼ -25.2 pp |
| 2019 | 59.9% | CN¥501.93 Million | CN¥305.29 Million | CN¥196.64 Million | CN¥838.26 Million | ▲ +0.3 pp |
| 2018 | 59.6% | CN¥485.70 Million | CN¥308.90 Million | CN¥176.80 Million | CN¥815.47 Million | ▲ +7.9 pp |
| 2017 | 51.7% | CN¥498.11 Million | CN¥321.51 Million | CN¥176.60 Million | CN¥963.72 Million | ▲ +0.7 pp |
| 2016 | 51.0% | CN¥486.58 Million | CN¥312.97 Million | CN¥173.60 Million | CN¥954.18 Million | ▲ +0.0 pp |
| 2015 | 50.9% | CN¥474.04 Million | CN¥316.12 Million | CN¥157.92 Million | CN¥930.46 Million | ▲ +15.0 pp |
| 2014 | 36.0% | CN¥281.32 Million | CN¥281.32 Million | CN¥- | CN¥782.00 Million | ▲ +6.2 pp |
| 2013 | 29.8% | CN¥230.37 Million | CN¥230.37 Million | CN¥- | CN¥772.70 Million | ▼ -2.1 pp |
| 2012 | 31.9% | CN¥219.68 Million | CN¥219.68 Million | CN¥- | CN¥687.93 Million | ▲ +0.5 pp |
| 2011 | 31.4% | CN¥203.84 Million | CN¥203.84 Million | CN¥- | CN¥648.25 Million | ▲ +6.4 pp |
| 2010 | 25.1% | CN¥148.61 Million | CN¥148.61 Million | CN¥- | CN¥592.55 Million | ▲ +7.9 pp |
| 2009 | 17.2% | CN¥97.00 Million | CN¥97.00 Million | CN¥- | CN¥563.53 Million | ▼ -44.4 pp |
| 2008 | 61.6% | CN¥48.49 Million | CN¥48.49 Million | CN¥- | CN¥78.73 Million | ▲ +46.4 pp |
| 2007 | 15.1% | CN¥8.83 Million | CN¥8.83 Million | CN¥- | CN¥58.27 Million | ▼ -13.9 pp |
| 2006 | 29.1% | CN¥5.62 Million | CN¥5.62 Million | CN¥- | CN¥19.33 Million | — |